do not receive it. There are 3 sources of costs that may arise from such under-utilisation: 1. increased morbidity and … mortality associated with under-use 2. increased demand for related medical resources when the health state following an AMI is …

. The effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality … replacement of older drugs by newer drugs. The effect of the vintage of chemotherapy treatments on age-adjusted cancer mortality … mortality rates, and may have accounted for as much as half of the decline. …

systematically review the published literature on the YPLL and the value of productivity loss from morbidity and premature mortality … results on YPLL, eight on mortality costs and five on morbidity costs. Some studies reported results in more than one category … per death and morbidity and mortality costs. The average number of YPLL per death was approximately 15 for melanoma and 10 …

hospitals, exceeding deaths caused by pneumonia and diabetes. The economic burden resulting from drug-related morbidity and … mortality is equally significant and has been conservatively estimated at $US30 billion dollars annually, and could exceed $US … drugs are capable of producing an injury, certain drugs are more likely to do so. Prevention of drug-related morbidity and …

lowered rates of total mortality and rehospitalisation due to heart failure. Design and Setting: The cost …